Nexalin receives Nasdaq delisting notice for equity shortfall; hearing set for Sept 1

Nexalin Technology, Inc.

• Stockholders' equity of $1,519,423 as of June 30, 2026, below $2,500,000 minimum required by Nasdaq Rule 5550(b)(1).
• Nasdaq also cites prior bid price deficiency; hearing before Panel scheduled for September 1, 2026.
• Company intends to present compliance plan at hearing; no assurance of continued listing.
• Delisting would materially harm liquidity, market price, and ability to raise capital.